News + Filings Transactions
|
NOHRA GUY P
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/16/2023 | Bioventus Inc. | BVS | Other (acquisition) | Class A Common Stock | 41.4k | $0.00 | $0 | | 08/16/2023 |
| 08/16/2023 | Bioventus Inc. | BVS | Other (disposition) | Class A Common Stock | 2.6M | $0.00 | $0 | See Footnote | 08/16/2023 |
| 06/07/2023 | Bioventus Inc. | BVS | Grant | Restricted Stock Units | 30.4k | $0.00 | $0 | | 06/06/2023 |
| 06/06/2023 | Bioventus Inc. | BVS | Exercise | Restricted Stock Units | 16.6k | $0.00 | $0 | | 06/06/2023 |
| 06/17/2022 | Bioventus Inc. | BVS | Grant | Restricted Stock Units | 16.6k | $0.00 | $0 | | 06/17/2022 |
| 04/01/2022 | Bioventus Inc. | BVS | Exercise | Restricted Stock Units | 2.7k | $0.00 | $0 | | 04/01/2022 |
| 02/11/2022 | Bioventus Inc. | BVS | Exercise | Restricted Stock Units | 9k | $0.00 | $0 | | 02/11/2022 |
| 04/01/2021 | Bioventus Inc. | BVS | Grant | Restricted Stock Units | 2.7k | $0.00 | $0 | | 04/01/2021 |
| 03/04/2021 | Allakos Inc. | ALLK | Sale | Common Stock | 2.3k | $108.89 | $250.4k | | 03/04/2021 |
| 03/04/2021 | Allakos Inc. | ALLK | Sale | Common Stock | 4k | $109.89 | $440.8k | | 03/04/2021 |
| 03/04/2021 | Allakos Inc. | ALLK | Sale | Common Stock | 3.1k | $110.84 | $348.3k | | 03/04/2021 |
| 03/04/2021 | Allakos Inc. | ALLK | Sale | Common Stock | 5.9k | $111.80 | $658.1k | | 03/04/2021 |
| 03/04/2021 | Allakos Inc. | ALLK | Sale | Common Stock | 9.3k | $113.01 | $1.1M | | 03/04/2021 |
| 03/04/2021 | Allakos Inc. | ALLK | Sale | Common Stock | 1.1k | $113.57 | $127.9k | | 03/04/2021 |
| 02/11/2021 | Bioventus Inc. | BVS | Grant | Restricted Stock Units | 9k | $0.00 | $0 | | 02/11/2021 |
| 06/17/2020 | Allakos Inc. | ALLK | Sale | Common Stock | 606 | $77.21 | $46.8k | | 06/17/2020 |
| 06/17/2020 | Allakos Inc. | ALLK | Sale | Common Stock | 1.4k | $76.52 | $108.2k | | 06/17/2020 |
| 06/17/2020 | Allakos Inc. | ALLK | Sale | Common Stock | 5.7k | $75.23 | $426.7k | | 06/17/2020 |
| 04/14/2015 | KalVista Pharmaceuticals, Inc. | KALV | Conversion | Convertible Promissory Note | 424.3k | $0.00 | $0 | See Footnote | 04/14/2015 |
| 04/14/2015 | KalVista Pharmaceuticals, Inc. | KALV | Conversion | Convertible Promissory Note | 333k | $0.00 | $0 | See Footnote | 04/14/2015 |
| 04/14/2015 | KalVista Pharmaceuticals, Inc. | KALV | Conversion | Common Stock | 727.6k | $0.00 | $0 | See Footnote | 04/14/2015 |
| 04/14/2015 | KalVista Pharmaceuticals, Inc. | KALV | Conversion | Common Stock | 2M | $0.00 | $0 | See Footnote | 04/14/2015 |
| 04/14/2015 | KalVista Pharmaceuticals, Inc. | KALV | Conversion | Common Stock | 424.3k | $0.00 | $0 | See Footnote | 04/14/2015 |
| 04/14/2015 | KalVista Pharmaceuticals, Inc. | KALV | Conversion | Common Stock | 333k | $0.00 | $0 | See Footnote | 04/14/2015 |
| 04/14/2015 | KalVista Pharmaceuticals, Inc. | KALV | Purchase | Common Stock | 877.5k | $5.00 | $4.4M | See Footnote | 04/14/2015 |
| 04/14/2015 | KalVista Pharmaceuticals, Inc. | KALV | Conversion | Series A Convertible Preferred Stock | 727.6k | $0.00 | $0 | See Footnote | 04/14/2015 |
| 04/14/2015 | KalVista Pharmaceuticals, Inc. | KALV | Conversion | Series B Convertible Preferred Stock | 2M | $0.00 | $0 | See Footnote | 04/14/2015 |
| 08/22/2014 | ZS Pharma, Inc. | ZSPH | Grant | Stock Option (right to buy) | 12k | $0.00 | $0 | | 08/22/2014 |
| 06/23/2014 | ZS Pharma, Inc. | ZSPH | Conversion | Common Stock | 3M | $0.00 | $0 | See Footnote | 06/23/2014 |
| 06/23/2014 | ZS Pharma, Inc. | ZSPH | Purchase | Common Stock | 200k | $18.00 | $3.6M | See Footnote | 06/23/2014 |
| 06/23/2014 | ZS Pharma, Inc. | ZSPH | Conversion | Series C Preferred Stock | 2.8M | $0.00 | $0 | See Footnote | 06/23/2014 |
| 06/23/2014 | ZS Pharma, Inc. | ZSPH | Conversion | Series D Preferred Stock | 180.4k | $0.00 | $0 | See Footnote | 06/23/2014 |
| 09/20/2013 | ACELRX PHARMACEUTICALS INC | ACRX | Sale | Common Stock | 96.5k | $10.84 | $1M | ACP IV, L.P. | 09/19/2013 |
| 09/19/2013 | ACELRX PHARMACEUTICALS INC | ACRX | Sale | Common Stock | 61.6k | $10.21 | $629.4k | ACP IV, L.P. | 09/19/2013 |
| 09/18/2013 | ACELRX PHARMACEUTICALS INC | ACRX | Sale | Common Stock | 62.5k | $10.29 | $642.5k | ACP IV, L.P. | 09/16/2013 |
|
|